Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.
Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Schizophr Res. 2021 Oct;236:12-18. doi: 10.1016/j.schres.2021.07.037. Epub 2021 Aug 4.
Autism spectrum disorders (ASD) symptoms are frequent in people living with schizophrenia spectrum disorders (SSD) and have a relevant impact on their daily life. However, current literature is mostly focused on investigating correlates of high levels of ASD symptoms, leaving largely unexplored the clinical, neurocognitive, socio-cognitive and functional characterization of individuals with minimal or absent ASD symptoms, which may represent a peculiar sub-population.
A total of 361 patients (mean age 41.7 years; 117 females) included in the SCOPE study were assessed with clinical, neurocognitive, socio-cognitive, functional capacity, social skills and real-world functioning measures. The severity of ASD symptoms was assessed with the PANSS Autism Severity Scale (PAUSS): individuals with a PAUSS score < 10 were considered without significant ASD symptoms.
Seventy-two (19.95%) participants had no significant ASD symptoms and presented a less severe clinical status, as well as a better cognitive and socio-cognitive performance and functional profile. Lower non-autistic SSD symptoms severity and better social skills, functional capacity, global cognitive and Theory of Mind/Mental State Attribution (as measured by the Hinting task) performance and real-world social relationships emerged as predictors of non-ASD symptoms status in the logistic regression analyses.
Individuals without ASD symptoms represent a minority of people diagnosed with SSD that appears to be characterized by specific correlates, resulting in a less severe situation and more positive outcomes. As these factors could have a relevant impact on treatment response, assessing the severity of ASD symptoms could be an important step required to define a personalized treatment.
自闭症谱系障碍(ASD)症状在患有精神分裂症谱系障碍(SSD)的人群中较为常见,对他们的日常生活有重要影响。然而,目前的文献主要集中在调查 ASD 症状水平较高的相关性,而对 ASD 症状轻微或不存在的个体的临床、神经认知、社会认知和功能特征的研究则相对较少,这些个体可能代表了一个特殊的亚人群。
共纳入 SCOPE 研究中的 361 名患者(平均年龄 41.7 岁;女性 117 名),使用临床、神经认知、社会认知、功能能力、社交技能和现实生活功能评估进行评估。使用 PANSS 自闭症严重程度量表(PAUSS)评估 ASD 症状的严重程度:PAUSS 评分<10 的患者被认为没有明显的 ASD 症状。
72 名(19.95%)患者没有明显的 ASD 症状,表现出较轻的临床状况,以及更好的认知和社会认知表现和功能特征。较低的非自闭症 SSD 症状严重程度和更好的社交技能、功能能力、整体认知和心理状态归因(以提示任务衡量)表现和现实生活中的社会关系,是逻辑回归分析中预测非 ASD 症状状态的因素。
没有 ASD 症状的个体在被诊断为 SSD 的人群中占少数,他们似乎具有特定的相关性,导致病情较轻,预后较好。由于这些因素可能对治疗反应有重要影响,因此评估 ASD 症状的严重程度可能是确定个性化治疗所需的重要步骤。